Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 314 entries
Sorted by: Best Match Show Resources per page
Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature.

International journal of surgery case reports

Macías I.
PMID: 27693837
Int J Surg Case Rep. 2016;28:93-96. doi: 10.1016/j.ijscr.2016.08.013. Epub 2016 Aug 13.

Portal hypertension is a clinical syndrome defined as a portal venous pressure that exceeds 10mmHg. Cirrhosis is the most common cause of portal hypertension and thrombosis of the splenoportal axis not associated with liver cirrhosis is the second cause...

Cite
Macías I. Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature. Int J Surg Case Rep. 2016;28:93-96doi: 10.1016/j.ijscr.2016.08.013.
Macías, I. (2016). Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature. International journal of surgery case reports, 2893-96. https://doi.org/10.1016/j.ijscr.2016.08.013
Macías, Isabel. "Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature." International journal of surgery case reports vol. 28 (2016): 93-96. doi: https://doi.org/10.1016/j.ijscr.2016.08.013
Macías I. Massive upper gastrointestinal bleeding due to splenoportal axis thrombosis in a patient with a tested JAK2 mutation: A case report and review literature. Int J Surg Case Rep. 2016;28:93-96. doi: 10.1016/j.ijscr.2016.08.013. Epub 2016 Aug 13. PMID: 27693837; PMCID: PMC5045565.
Copy Download .nbib Format: NLM
Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease.

Clinical kidney journal

Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J.
PMID: 28396734
Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08.

No abstract available.

Cite
Vega A, Abad S, Macías N, et al. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017;10(2):170-175doi: 10.1093/ckj/sfw126.
Vega, A., Abad, S., Macías, N., Aragoncillo, I., Santos, A., Galán, I., Cedeño, S., & Manuel López-Gómez, J. (2017). Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clinical kidney journal, 10(2), 170-175. https://doi.org/10.1093/ckj/sfw126
Vega, Almudena, et al. "Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease." Clinical kidney journal vol. 10,2 (2017): 170-175. doi: https://doi.org/10.1093/ckj/sfw126
Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08. PMID: 28396734; PMCID: PMC5381238.
Copy Download .nbib Format: NLM
Collision-induced dissociation of phenethylamides: role of ion-neutral complexes.

Rapid communications in mass spectrometry : RCM

Nikolić D, Macias C, Lankin DC, van Breemen RB.
PMID: 28558170
Rapid Commun Mass Spectrom. 2017 Sep 15;31(17):1385-1395. doi: 10.1002/rcm.7915.

RATIONALE: Phenethylamides are a large group of naturally occurring molecules found both in the plant and animal kingdoms. In addition, they are used as intermediates for the synthesis of pharmaceutically important dihydro- and tetrahydroisoquinolines. To enable efficient characterization of...

Cite
Nikolić D, Macias C, Lankin DC, et al. Collision-induced dissociation of phenethylamides: role of ion-neutral complexes. Rapid Commun Mass Spectrom. 2017;31(17):1385-1395doi: 10.1002/rcm.7915.
Nikolić, D., Macias, C., Lankin, D. C., & van Breemen, R. B. (2017). Collision-induced dissociation of phenethylamides: role of ion-neutral complexes. Rapid communications in mass spectrometry : RCM, 31(17), 1385-1395. https://doi.org/10.1002/rcm.7915
Nikolić, Dejan, et al. "Collision-induced dissociation of phenethylamides: role of ion-neutral complexes." Rapid communications in mass spectrometry : RCM vol. 31,17 (2017): 1385-1395. doi: https://doi.org/10.1002/rcm.7915
Nikolić D, Macias C, Lankin DC, van Breemen RB. Collision-induced dissociation of phenethylamides: role of ion-neutral complexes. Rapid Commun Mass Spectrom. 2017 Sep 15;31(17):1385-1395. doi: 10.1002/rcm.7915. PMID: 28558170; PMCID: PMC5555735.
Copy Download .nbib Format: NLM
The agrobacterium tumefaciens C58-6b gene confers resistance to N(6)-benzyladenine without modifying cytokinin metabolism in tobacco seedlings.

Planta

Galis I, Simek P, Macas J, Zahradnickova H, Vlasak J, Wabiko H, Van Dongen W, Van Onckelen HA, Ondrej M.
PMID: 10550626
Planta. 1999 Oct;209(4):453-61. doi: 10.1007/s004250050748.

The 6b gene of Agrobacterium tumefaciens has been demonstrated to modify the activity of the plant growth regulators, auxin and cytokinin. To study the possible mode of action of the gene, tobacco (Nicotiana tabacum L. cv. Samsun) plants were...

Cite
Galis I, Simek P, Macas J, et al. The agrobacterium tumefaciens C58-6b gene confers resistance to N(6)-benzyladenine without modifying cytokinin metabolism in tobacco seedlings. Planta. 1999;209(4):453-61doi: 10.1007/s004250050748.
Galis, I., Simek, P., Macas, J., Zahradnickova, H., Vlasak, J., Wabiko, H., Van Dongen W, Van Onckelen HA, & Ondrej, M. (1999). The agrobacterium tumefaciens C58-6b gene confers resistance to N(6)-benzyladenine without modifying cytokinin metabolism in tobacco seedlings. Planta, 209(4), 453-61. https://doi.org/10.1007/s004250050748
Galis, et al. "The agrobacterium tumefaciens C58-6b gene confers resistance to N(6)-benzyladenine without modifying cytokinin metabolism in tobacco seedlings." Planta vol. 209,4 (1999): 453-61. doi: https://doi.org/10.1007/s004250050748
Galis I, Simek P, Macas J, Zahradnickova H, Vlasak J, Wabiko H, Van Dongen W, Van Onckelen HA, Ondrej M. The agrobacterium tumefaciens C58-6b gene confers resistance to N(6)-benzyladenine without modifying cytokinin metabolism in tobacco seedlings. Planta. 1999 Oct;209(4):453-61. doi: 10.1007/s004250050748. PMID: 10550626.
Copy Download .nbib Format: NLM
Barium Templating Schiff-Base Lateral Macrobicycles.

Inorganic chemistry

Esteban D, Bañobre D, Bastida R, de Blas A, Macías A, Rodríguez A, Rodríguez-Blas T, Fenton DE, Adams H, Mahía J.
PMID: 11670968
Inorg Chem. 1999 Apr 19;38(8):1937-1944. doi: 10.1021/ic9811190.

Schiff-base lateral macrobicycles containing two different binding units, a rigid and unsaturated N(2)X set (X: N, O) and a flexible and cyclic N(2)O(n)() set, linked by two aromatic bridges, have been prepared by reaction of the appropriate bibracchial diamines...

Cite
Esteban D, Bañobre D, Bastida R, et al. Barium Templating Schiff-Base Lateral Macrobicycles. Inorg Chem. 1999;38(8):1937-1944doi: 10.1021/ic9811190.
Esteban, D., Bañobre, D., Bastida, R., de Blas, A., Macías, A., Rodríguez, A., Rodríguez-Blas, T., Fenton, D. E., Adams, H., & Mahía, J. (1999). Barium Templating Schiff-Base Lateral Macrobicycles. Inorganic chemistry, 38(8), 1937-1944. https://doi.org/10.1021/ic9811190
Esteban, David, et al. "Barium Templating Schiff-Base Lateral Macrobicycles." Inorganic chemistry vol. 38,8 (1999): 1937-1944. doi: https://doi.org/10.1021/ic9811190
Esteban D, Bañobre D, Bastida R, de Blas A, Macías A, Rodríguez A, Rodríguez-Blas T, Fenton DE, Adams H, Mahía J. Barium Templating Schiff-Base Lateral Macrobicycles. Inorg Chem. 1999 Apr 19;38(8):1937-1944. doi: 10.1021/ic9811190. PMID: 11670968.
Copy Download .nbib Format: NLM
Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation.

BMC nuclear medicine

Zhang Z, Machac J, Helft G, Worthley SG, Tang C, Zaman AG, Rodriguez OJ, Buchsbaum MS, Fuster V, Badimon JJ.
PMID: 16725052
BMC Nucl Med. 2006 May 25;6:3. doi: 10.1186/1471-2385-6-3.

BACKGROUND: Coronary atherosclerosis and its thrombotic complications are the major cause of mortality and morbidity throughout the industrialized world. Thrombosis on disrupted atherosclerotic plaques plays a key role in the onset of acute coronary syndromes. Macrophages density is one...

Cite
Zhang Z, Machac J, Helft G, et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med. 2006;6:3doi: 10.1186/1471-2385-6-3.
Zhang, Z., Machac, J., Helft, G., Worthley, S. G., Tang, C., Zaman, A. G., Rodriguez, O. J., Buchsbaum, M. S., Fuster, V., & Badimon, J. J. (2006). Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC nuclear medicine, 63. https://doi.org/10.1186/1471-2385-6-3
Zhang, Zhuangyu, et al. "Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation." BMC nuclear medicine vol. 6 (2006): 3. doi: https://doi.org/10.1186/1471-2385-6-3
Zhang Z, Machac J, Helft G, Worthley SG, Tang C, Zaman AG, Rodriguez OJ, Buchsbaum MS, Fuster V, Badimon JJ. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med. 2006 May 25;6:3. doi: 10.1186/1471-2385-6-3. PMID: 16725052; PMCID: PMC1479805.
Copy Download .nbib Format: NLM
Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study.

Evidence-based complementary and alternative medicine : eCAM

Clavo B, Ruiz A, Lloret M, López L, Suárez G, Macías D, Rodríguez V, Hernández MA, Martín-Oliva R, Quintero S, Cuyás JM, Robaina F.
PMID: 15841266
Evid Based Complement Alternat Med. 2004 Dec;1(3):321-325. doi: 10.1093/ecam/neh038. Epub 2004 Oct 16.

Advanced head and neck (H&N) tumors have a poor prognosis, and this is worsened by the occurrence of hypoxia and ischemia in the tumors. Ozonetherapy has proved useful in the treatment of ischemic syndromes, and several studies have described...

Cite
Clavo B, Ruiz A, Lloret M, et al. Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study. Evid Based Complement Alternat Med. 2004;1(3):321-325doi: 10.1093/ecam/neh038.
Clavo, B., Ruiz, A., Lloret, M., López, L., Suárez, G., Macías, D., Rodríguez, V., Hernández, M. A., Martín-Oliva, R., Quintero, S., Cuyás, J. M., & Robaina, F. (2004). Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study. Evidence-based complementary and alternative medicine : eCAM, 1(3), 321-325. https://doi.org/10.1093/ecam/neh038
Clavo, Bernardino, et al. "Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study." Evidence-based complementary and alternative medicine : eCAM vol. 1,3 (2004): 321-325. doi: https://doi.org/10.1093/ecam/neh038
Clavo B, Ruiz A, Lloret M, López L, Suárez G, Macías D, Rodríguez V, Hernández MA, Martín-Oliva R, Quintero S, Cuyás JM, Robaina F. Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study. Evid Based Complement Alternat Med. 2004 Dec;1(3):321-325. doi: 10.1093/ecam/neh038. Epub 2004 Oct 16. PMID: 15841266; PMCID: PMC538509.
Copy Download .nbib Format: NLM
Regional highlights in global emergency medicine development.

Emergency medicine clinics of North America

Doney MK, Macias DJ.
PMID: 15663972
Emerg Med Clin North Am. 2005 Feb;23(1):31-44. doi: 10.1016/j.emc.2004.09.011.

There are a number of notable trends in the development of EM that have been highlighted at the regional level globally. From the establishment of formal EM training as the standard of care to practice in an ED to...

Cite
Doney MK, Macias DJ. Regional highlights in global emergency medicine development. Emerg Med Clin North Am. 2005;23(1):31-44doi: 10.1016/j.emc.2004.09.011.
Doney, M. K., & Macias, D. J. (2005). Regional highlights in global emergency medicine development. Emergency medicine clinics of North America, 23(1), 31-44. https://doi.org/10.1016/j.emc.2004.09.011
Doney, Michael K, and Macias, Darryl J. "Regional highlights in global emergency medicine development." Emergency medicine clinics of North America vol. 23,1 (2005): 31-44. doi: https://doi.org/10.1016/j.emc.2004.09.011
Doney MK, Macias DJ. Regional highlights in global emergency medicine development. Emerg Med Clin North Am. 2005 Feb;23(1):31-44. doi: 10.1016/j.emc.2004.09.011. PMID: 15663972.
Copy Download .nbib Format: NLM
7-(tert-Butyl-diphenyl-sil-yloxy)-2,2-dimethyl-1-benzofuran-3(2H)-one.

Acta crystallographica. Section E, Structure reports online

Salas CO, Tapia RA, Macías A.
PMID: 21523052
Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 12;67:o375. doi: 10.1107/S1600536810054462.

The title compound, C(26)H(28)O(3)Si, is an allylic oxidation product of the tert-but-yl(2,2-dimethyl-2,3-dihydro-benzo-furan-7-yl-oxy)diphenyl-silane with N-bromo-succinimide and 2,2'-azobis-isobutyronitrile. The nine-atom bicyclic system is almost planar, with an r.m.s deviation of 0.0123 (2) Å and a maximum deviation of 0.031 (2) Å...

Cite
Salas CO, Tapia RA, Macías A. 7-(tert-Butyl-diphenyl-sil-yloxy)-2,2-dimethyl-1-benzofuran-3(2H)-one. Acta Crystallogr Sect E Struct Rep Online. 2011;67:o375doi: 10.1107/S1600536810054462.
Salas, C. O., Tapia, R. A., & Macías, A. (2011). 7-(tert-Butyl-diphenyl-sil-yloxy)-2,2-dimethyl-1-benzofuran-3(2H)-one. Acta crystallographica. Section E, Structure reports online, 67o375. https://doi.org/10.1107/S1600536810054462
Salas, Cristian O, et al. "7-(tert-Butyl-diphenyl-sil-yloxy)-2,2-dimethyl-1-benzofuran-3(2H)-one." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): o375. doi: https://doi.org/10.1107/S1600536810054462
Salas CO, Tapia RA, Macías A. 7-(tert-Butyl-diphenyl-sil-yloxy)-2,2-dimethyl-1-benzofuran-3(2H)-one. Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 12;67:o375. doi: 10.1107/S1600536810054462. PMID: 21523052; PMCID: PMC3051744.
Copy Download .nbib Format: NLM
Retrieval of relevant parameters of natural multilayer systems by means of bio-inspired optimization strategies.

Applied optics

Macías D, Luna A, Skigin D, Inchaussandague M, Vial A, Schinca D.
PMID: 23670781
Appl Opt. 2013 Apr 10;52(11):2511-20. doi: 10.1364/AO.52.002511.

Natural photonic structures exhibit remarkable color effects such as metallic appearance and iridescence. A rigorous study of the electromagnetic response of such complex structures requires to accurately determine some of their relevant optical parameters, such as the refractive indices...

Cite
Macías D, Luna A, Skigin D, et al. Retrieval of relevant parameters of natural multilayer systems by means of bio-inspired optimization strategies. Appl Opt. 2013;52(11):2511-20doi: 10.1364/AO.52.002511.
Macías, D., Luna, A., Skigin, D., Inchaussandague, M., Vial, A., & Schinca, D. (2013). Retrieval of relevant parameters of natural multilayer systems by means of bio-inspired optimization strategies. Applied optics, 52(11), 2511-20. https://doi.org/10.1364/AO.52.002511
Macías, Demetrio, et al. "Retrieval of relevant parameters of natural multilayer systems by means of bio-inspired optimization strategies." Applied optics vol. 52,11 (2013): 2511-20. doi: https://doi.org/10.1364/AO.52.002511
Macías D, Luna A, Skigin D, Inchaussandague M, Vial A, Schinca D. Retrieval of relevant parameters of natural multilayer systems by means of bio-inspired optimization strategies. Appl Opt. 2013 Apr 10;52(11):2511-20. doi: 10.1364/AO.52.002511. PMID: 23670781.
Copy Download .nbib Format: NLM
Atopic dermatitis guideline. Position paper from the Latin American Society of Allergy, Asthma and Immunology.

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Sánchez J, Páez B, Macías A, Olmos C, de Falco A.
PMID: 25177854
Rev Alerg Mex. 2014 Jul-Sep;61(3):178-211.

As in other regions, the incidence of atopic dermatitis in Latin America has been increasing in recent years. Although there are several clinical guidelines, many of their recommendations cannot be universal since they depend on the characteristics of each...

Cite
Sánchez J, Páez B, Macías A, et al. Guía de dermatitis atópica. Consenso de la Sociedad Latinoamericana de Alergia, Asma e Inmunología. Atopic dermatitis guideline. Position paper from the Latin American Society of Allergy, Asthma and Immunology. Rev Alerg Mex. 2014;61(3):178-211
Sánchez, J., Páez, B., Macías, A., Olmos, C., & de Falco, A. (2014). Guía de dermatitis atópica. Consenso de la Sociedad Latinoamericana de Alergia, Asma e Inmunología. Atopic dermatitis guideline. Position paper from the Latin American Society of Allergy, Asthma and Immunology. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993), 61(3), 178-211.
Sánchez, Jorge, et al. "Guía de dermatitis atópica. Consenso de la Sociedad Latinoamericana de Alergia, Asma e Inmunología." Atopic dermatitis guideline. Position paper from the Latin American Society of Allergy, Asthma and Immunology. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) vol. 61,3 (2014): 178-211.
Sánchez J, Páez B, Macías A, Olmos C, de Falco A. Guía de dermatitis atópica. Consenso de la Sociedad Latinoamericana de Alergia, Asma e Inmunología. Atopic dermatitis guideline. Position paper from the Latin American Society of Allergy, Asthma and Immunology. Rev Alerg Mex. 2014 Jul-Sep;61(3):178-211. PMID: 25177854.
Copy Download .nbib Format: NLM
Anti-idiotype antibodies in cancer treatment.

Frontiers in oncology

Gomez DE, Vázquez AM, Alonso DF, Macías A.
PMID: 23447805
Front Oncol. 2013 Feb 26;3:37. doi: 10.3389/fonc.2013.00037. eCollection 2013.

No abstract available.

Cite
Gomez DE, Vázquez AM, Alonso DF, et al. Anti-idiotype antibodies in cancer treatment. Front Oncol. 2013;3:37doi: 10.3389/fonc.2013.00037.
Gomez, D. E., Vázquez, A. M., Alonso, D. F., & Macías, A. (2013). Anti-idiotype antibodies in cancer treatment. Frontiers in oncology, 337. https://doi.org/10.3389/fonc.2013.00037
Gomez, Daniel E, et al. "Anti-idiotype antibodies in cancer treatment." Frontiers in oncology vol. 3 (2013): 37. doi: https://doi.org/10.3389/fonc.2013.00037
Gomez DE, Vázquez AM, Alonso DF, Macías A. Anti-idiotype antibodies in cancer treatment. Front Oncol. 2013 Feb 26;3:37. doi: 10.3389/fonc.2013.00037. eCollection 2013. PMID: 23447805; PMCID: PMC3581801.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 314 entries